FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072582 [Registered on: 16/08/2024] Trial Registered Prospectively
Last Modified On: 09/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Study to Test How Two Traditional Treatments Help Improve Uterine Health 
Scientific Title of Study   A single arm clinical study to evaluate the combined effect of Shatapushpa taila Nasya and Phala sarpi yoni pichu in improving the endometrial receptivity 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Prashant Zinjad 
Designation  PG Scholar 
Affiliation  Amrita School of Ayurveda 
Address  Department of Stree roga and Prasuti tantra, Amrita School of Ayurveda Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O. Kerala, India

Kollam
KERALA
690546
India 
Phone  7038477341  
Fax    
Email  prashantzinjad2@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Hemavathi S K 
Designation  HOD and Professor  
Affiliation  Amrita School of Ayurveda 
Address  Department of Stree roga and Prasuti tantra, Amrita School of Ayurveda Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O.

Kollam
KERALA
690546
India 
Phone  9446962291  
Fax    
Email  hemavathi@ay.amrita.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Hemavathi S K 
Designation  HOD and Professor  
Affiliation  Amrita School of Ayurveda 
Address  Department of Stree roga and Prasuti tantra, Amrita School of Ayurveda Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O.

Kollam
KERALA
690546
India 
Phone  9446962291  
Fax    
Email  hemavathi@ay.amrita.edu  
 
Source of Monetary or Material Support  
Sparsh Womens Hospital and IVF center 
 
Primary Sponsor  
Name  Dr. Prashant Zinjad 
Address  Department of Stree roga and Prasuti tantra, Amrita School of Ayurveda Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O. 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prashant zinjad  Sparsh Womens Hospital and IVF Center  Plot no. ASG 44/45 sahyadri nagar, Ashwin Nagar, Nashik, Maharashtra 422010
Nashik
MAHARASHTRA 
7038477341

prashantzinjad2@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
SMBT ayurved ethics committee  Approved 
sparsh womens hospital and IVF center  No Objection Certificate 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N859||Noninflammatory disorder of uterus, unspecified. Ayurveda Condition: ARTAVAVAHA-SROTODUSHTIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: shatapushpa taila, Reference: kashyapa samhita, Shatapushpa-shatavari Adhyaya, Route: Nasal, Dosage Form: Taila, Dose: 1.5(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: 0.75 ml in each nostril
(2) Medicine Name: phala sarpi, Reference: Astanga hrudayam uttarstana 34 chapter 63 to 67 shloka, Route: Vaginal, Dosage Form: Ghrita, Dose: 5(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: sterile pichu will be dipped in phala sarpi and kept in vagina
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Females in age group 20-35yrs, Having an endometrial thickness of less tha or equal to 7mm or having an Applebaum’s (USSR) Score less than 16 out of 20 in the Pre-test, With a Menstrual cycle between 24-38 days, Who are eligible for TVS scan.
 
 
ExclusionCriteria 
Details  Subjects having compliance with the interventions Females who are already diagnosed with Carcinoma of the reproductive tract, Congenital anomalies of the reproductive tract, Active inflammatory disease, Sexually transmitted infections, and Uncontrolled systemic diseases such as diabetes and hypertension, Subjects who are on Oral-contraceptive from the last 3 menstrual cycles, Subjects unfit for nasya intervention.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in Applebaums USSR score  3 menstrual cycle of the patient 
 
Secondary Outcome  
Outcome  TimePoints 
Difference in menstrual cycle in terms of frequency, duration and flow volume  3 menstrual cycle of the patient 
 
Target Sample Size   Total Sample Size="12"
Sample Size from India="12" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   30/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

PROPOSED TITLE :

 

“A SINGLE-ARM CLINICAL STUDY TO EVALUATE THE COMBINED EFFECT OF SHATAPUSHPA TAILA NASYA AND PHALA SARPI YONI PICHU IN IMPROVING ENDOMETRIAL RECEPTIVITY”

 

INTRODUCTION :

The ability of the endometrium to allow implantation is known as receptivity. Optimal receptivity is essential for a healthy pregnancy. Females who have poor endometrial quality may face various menstrual and infertility problems, often resulting from a thin endometrium. The endometrium undergoes changes during the menstrual cycle, and estrogen plays a critical role in the endometrial sensitivity to ovarian hormones. Any disturbance in estrogen levels can result in a thin endometrium. Treatment for a thin endometrium involves synthetic estrogen administration, which can cause severe side effects. Thus, alternative methods are required to regulate estrogen synthesis and improve endometrial quality. According to Sushruta Samhita, four crucial factors are required for conception in which “ Kshetra” is Garbhashaya, which can be correlated to endometrium. Acharya Sushruta has mentioned pre-conceptional care, whereas Dalhanacharya focuses on Garbhasthapana and Garbhastitikarana. Acharya Vishwamitra’s commentary on Sushruta Samhita mentions presence sukshma kesha pratikasha beeja raktavaha sira in garbhashaya which can be correlated in the context of garbhashya tarpana. Phalasarpi has Garbha sthapaka , Yoni doshahara, Putrapada, Pumsavana properties. In Kashyapa Samhita, Shatapushpa-Shatavari kapla adhyaya, Shatapushpa is mentioned as having properties of rutupravartani, yonivishodhana, putraprada and veeryakari. Shatapushpa also known as Anethum sowa Roxb contains phytoestrogens that exhibit properties similar to endogenous estrogen. Nasal administration allows for a quick local effect and has a direct effect on the hypothalamo-pituitary axis, which leads to ovarian stimulation and ultimately impacts the endometrium. Drug administration through the vaginal route is effective due to better drug bioavailability to the uterus, hence can be given to improve endometrium receptivity.

METHODOLOGY : Minimum of 12 participants satisfying inclusion criteria will be selected from Sparsh women’s Hospital and IVF centre, after getting IEC clearance from SMBT Ayurveda College and CTRI registration.The baseline data will be assessed using Applebaum’s (USSR) score on the day of recruitment of the study, Day 15th of menstrual cycle (M1) after getting written informed consent. Treatment will be initiated with pratimarsha nasya using Shatapushpa taila from Day 6th – Day 13th of the immediate menstrual cycle (M2), Then from Day 15th-Day 21st of the same menstrual cycle (M2), yoni pichu with sterile Phalasarpi will be given. Post-assessment will be done on Day 15th of next menstrual cycle (M3) using Applebaum’s (USSR) score. This score will be compared with their initial score to determine the effectiveness of the treatment.

DURATION OF THE STUDY – 18 MONTHS

ESTIMATED COST – Approximately Rs. 67,000/- 

 
Close